Bis(2,6-(2′,6′-diisoproylanil)diformyl-4-chloro-phenolate) nickel(II)

Bis(2,6-(2,6-diisoproylanil)diformyl-4-chloro-phenolate) nickel(II) was prepared by the reaction of 2,6-(2,6-diisoproylanil)diformyl-4-chloro-phenol with nickel chloride. The title complex crystallized in P2₁/c, with cell dimensions a = 9.962(2) Å, b = 12.087(3) Å, c = 24.445(6) Å, and = 97.032(5), giving a volume of 2921.4(13) ų. The bis(2,6-(2,6-diisoproylanil)diformyl-4-chloro-phenolate) nickel(II) adapts an ideal parallelogram, in which the Ni atom is coordinated with two phenolic oxygen atoms [O(1), O(1A)] and two imino nitrogen atoms [N(1), N(1A)].     

Hydrogen bonds and π–π stacking interaction in 4′, 7-dimethoxylisoflavone and 4′,7-diacetyl-O-isoflavone

4′,7-dimethoxylisoflavone, C₁₇H₁₄O₄, (I), is linked into a supramolecular structure by a variety of weak but direction-specific intermolecular forces, the molecules are linked into chains through C–H⋅sO hydrogen bonds, these chains are further linked by face-to-face (F-tape) π–π stacking into a one-dimensional bi-chain, another type π–π stacking, edge-to-face (T-tape), assemble the bi-chain into framework together with C–H⋅sO hydrogen bonds. 4′,7-diacetyl-O-isoflavone, C₁₉H₁₅O₆, (II), shows some discrepancies with I and the molecules are assembled into framework all by C–H⋅sO hydrogen bonds. The molecules are linked into centrosymmetric dimers built from classic R₂² (8) rings by pairs of C–H⋅sO hydrogen bonds, the dimers are linked into (011) sheets by combination of the R₂² (8) ring and C–H⋅sO hydrogen bonds, another C–H⋅sO hydrogen bond assemble the sheets into three-dimensional network.     

The structure of Wallach's compound. Single-crystal X-ray structure determination oftrans-2,5-bis(trichloromethyl)-N-(1′-hydroxy-2′,2′,2′-trichloroethyl)-4-imino-1,3-dioxolane

The structure of Wallach's compound, C₇H₄O₃NCl₉, prepared in 1874 from concentrated aqueous solutions of potassium cyanide and chloral hydrate, has long been undecided. By single crystal X-ray crystallography it has now been established astrans-2,5-bis(trichloromethyl)-N-(1-hydroxy-2,2,2-trichloroethyl)-4-imino-1,3-dioxolane, confirming the tentative assignment by¹H and¹³C NMR spectrography. The title compound is monoclinic,P2₁/c;a=8.445 (1),b=10.948(1),c=17.923(4) Å;=94.36(1)°;Z=4. The structure was solved by direct methods, from data collected at room temperature on an Enraf-Nonius CAD4 diffractometer, and refined by least squares to a finalR value of 0.041 using 2101 reflections.     

4′-(4-(4-羧基苯氧基)苯基-4,2′6′,4″-三联吡啶的 合成、晶体结构及性质研究

以4-乙酰基吡啶及对氯苯甲醛为原料合成了一例新的化合物4′-(4-(4-羧基苯氧基)苯基-4,2′6′,4″-三联吡啶,用元素分析、红外光谱、紫外光谱、X射线单晶衍射对此化合物进行了表征,结果表明,该化合物属于P2(1)/c空间群,晶胞参数为:a=1.4405(5)nm,b=0.7708(2)nm,c=2.0567(7)nm,β=107.699(6)°.     

Synthesis and Structural Characterization of (2,4-Diamino-5-(3′,4′,5′-Trimethoxybenzyl)Pyrimidine Copper (II)) Complex

Abstract  The reaction of Cu(OOCCH₃)₂·H₂O with (2,4-diamino-5-(3′,4′,5′-trimethoxybenzyl) pyrimidine (trimethoprim) in ethanolic solution at 80 °C affords the title complex which has been characterized by elemental, IR, and NMR (¹H and ¹³C).The crystal structure has been determined by single crystal X-ray diffraction. Compound 1 (C₃₆H₄₈Cu₂N₈O₁₄) is triclinic, space group P-1 with a = 7.2676(4) ?, b = 11.6721(7) ?, c = 12.8279(8) ?, α = 95.839(1)°, β = 93.456(1)°, γ = 105.541(1)°, Z = 1. Two copper atoms are coordinated directly to each other as well as are held together by four bridging aceto groups. Each copper atom is also bonded opposite the Cu–Cu vector to a trimethoprim molecule through the N(1) atom of the pyrimidine ring. Trimethoprim acts as a monodentate ligand through the pyrimidine nitrogen N(1) atom. The complex was screened for the activity against several bacteria, showing more activity against bacteria as compared to trimethoprim. Graphical Abstract  To enhance the activity of trimethoprim, its derivative was prepared and there bacterial activity against several bacteria was analyzed.      

2-甲基4-(4-(吡啶-3-乙炔基)苯基)-3-丁炔-2-醇的合成及晶体结构

由1,4-二碘代苯出发,经过两步Sonogashira偶联反应合成了标题配合物2-甲基4.(4-(吡啶-3-乙炔基)苯基)-3-丁炔-2-醇.通过1H NMR、13C NMR核磁共振、Ⅹ-射线单晶衍射等手段对化合物的结构进行了表征.结果表明,该化合物晶体属于单斜晶系,空间群为P21/c.晶体学参数:a=3.3321 (4) nm,b=1.00539(11) nm,c=0.89158(10) nm,α =90.00°,β=92.442(2)°,y=90.00°,V=2984.2(6) nm3,Z =4.     

Crystal structure of (4α,4aα,8aα)-(±)-octahydro-2-(phenylmethyl)-2H-1,2-benzoxazin-4-ol, 4-methylbenzenesulfonate(ester)

The title compound, a bicyclic tetrahydro-1,2-oxazine, crystallizes in a monoclinic lattice, space group P2₁/c, with a = 12.9809(18)Å, b = 12.920(2)Å, c = 13.631(2)Å, = 110.713(12)°, and Z = 4. The structure found in the solid state for this conformationally mobile molecule shows the tosyl group in an axial position and a benzyl group in an equatorial position of the bicyclic system.     

Crystal and molecular structure of 2-(7-cyanonorcaran-7-yl)-5-(ethoxycarbonyl)-4,5,6,11b-tetrahydro(Δ4-1,2,4-oxadiazolino)-[2,3-a]-β-carboline,C23H24N4O3

The structure of the title compound, C₂₃H₂₄N₄O₃, was determined by X-rays.M _r =404.47, orthorhombic, space groupPna2₁; unit cell dimensionsa=9.0386(4),b=28.0249(14),c=7.8936(9) Å,V _c =1999.49(3) ų,Z=4,D _x =1.344 Mg m^–1. CuK radiation (graphite crystal monochromator, =1.54178 Å),(CuK)=0.699 mm^–1,F(000)=856,T=295 K. Final conventionalR-factor=0.030,R _w =0.037 for 3215 unique reflections and 366 variables. The structure was solved by automated rotation functions in vector space, usingDirdif. The absolute configuration of the structure is reported.     

Synthesis and crystal structure of 1-(1′,3′-dimethyl-5′-chloropyrazol-4′-carbonyl′-3-(2′-chlorophenyl)-5-amino-4-cyanopyrazole

The title compound 1-(1,3-dimethyl-5-chloropyrazol-4-carbonyl)-3-(2-chlorophenyl)-5-amino-4-cyanopyrazole (C₁₆H₁₂Cl₂N₆O) has been synthesized and characterized by X-ray diffraction: Triclinic, space group P1, with a = 8.6712(8) Å, b = 9.5091(10) Å, c = 11.2170(11) Å = 71.531(2)°, = 84.683(2)°, = 74.099(2)° Z = 2; V = 843.7(14) ų. C(10), O(1), C(11), and N(2) atoms are coplanar with the average deviation of 0.0071 Å, which form 11.03° and 43.93° dihedral angles with pyrazole planes (I) and (II), respectively.     

Crystal and molecular structure of CI Solvent Yellow 18, 4-(2′,4′-dimethyl phenyl hydrazono)-5-methyl-2-phenyl-3H-pyrazol-3-one

The crystal structure of CI Solvent Yellow 18, C₁₈H₁₈N₄O, has been determined by single crystal X-ray diffraction techniques. It crystallizes in the monoclinic system witha=7.480(2) Å,b=19.184(3) Å,c=11.260(1) Å,=98.00(3)°, space groupP2₁/n andZ=4. The structure has been solved by direct methods, and least-squares refinement has been completed on three-dimensional data (2310 reflections, CuK radiation). The hydrogen atoms have been found, but only their positional parameters refined. Final residual 0.085 (all positive intensity data). The molecule exists as the hydrazone tautomer and intramolecular hydrogen bonding keep the molecule approximately planar. The molecules are packed in layers parallel to the (¯202) plane and in columns parallel tob. Alternate molecules within the columns are in antiparallel. The molecules are linked by van der Waals' forces.     

Crystal structure of 4-phenyl-3,5-dioxacyclohexyl-1, 1′-cyclopentane-2′,3″-(1,5,8,11-tetraoxacyclotridecane)

The structure of the title compound is determined by X-ray diffraction (DAR-UMB diffractometer, θ-θ/2θ scan mode, MoK _α radiation, direct method). The crystal is monoclinic, a = 24.582(6) Å, b = 22.812(8) Å, c = 8.647(3) Å, γ = 60.64(2)°, ρ _calcd = 1.232 g/cm³ space group A2/a, and Z = 8 for C₂₂H₃₂O₆. The molecule consists of four fragments: 13-crown-4 (A), 1,3-dioxane (B), a five-membered ring (C) acting as a bridge between fragments A and B, and a phenyl ring (D). Introduction of the bulky ring C as a bridge into the molecule results in significant deviations (up to ±0.014 Å) of the ether O atoms from planarity. The conformation of the macrocyclic fragment is [3433] according to the Dale notation. The C—H?O 1,4-interactions, which are energetically favorable occur in the propylene part of 13-crown-4: the C(2)?O(5) and C(4)?O(1) distances are 2.82 Å. The molecules in the structure form planar networks parallel to the xy plane. The intermolecular contacts correspond to the van der Waals interactions.     

Novel manganese(III) oxidation chemistry: X-ray crystal structures of (1α,2α,4β)-1,2-diacetoxy-4-(4-methoxyphenyl)-6-methoxy-1,2,3,4-tetrahydronaphthalene (compound A) and (1α,2α,4β)-1,2-diacetoxy-4-(2-methoxyphenyl)-8-methoxy-1,2,3,4-tetrahydronaphthalene (compound B)

CompoundA is (1,2,4)-1,2-diacetoxy-4-(4-methoxyphenyl)-6-methoxy-l,2,3,4-tetrahydronaphthalene, C₂₂H₂₄O₆,M _r=384.43, monoclinic, P2₁/n, witha=11.074(3),b=10.353(4),c=17.616(4)Å,=94.96(2)°,V=2012.1ų,D _calc=1.27 g cm^–3 and=0.55 cm^–1 forZ=4. Least-squares refinement of 1371 observed [F ₀5 (F ⁰)] reflections led to the final agreement index ofR=0.052. A twofold disorder was observed for the 1-acetoxy group whereas the 2-acetoxy group was ordered. CompoundB, (1,2,4)-1,2-diacetoxy-4-(2-methoxyphenyl)-8-methoxy-l,2,3,4-tetrahydronaphthalene, C₂₂H₂₄O₆,M _r=384.43, crystallizes in the monoclinic space group, P2₁/c, witha=16.209(2),b=10.076(1),c=13.357(4)Å,=111.41(2)°,V=2030.9ų,D _calc=1.26 g cm^–3 and=0.54 cm^–1 forZ=4. A final agreement index ofR=0.045 was realized by least-squares refinement of 1486 observed [F _o5 (F _o)] reflections. Intermolecular interactions in the cell lattices of compoundsA andB are noted. The title compoundsA andB were prepared by manganese(III) acetate oxidative dimerization of two molecules of 4-methoxystyrene and 2-methoxystyrene, respectively.     

A structural model for a new class of conformationally constrained retinoid: (2Z,4E)-4-[3′,4′-dihydro-1′(2′H)-naphthalene-1′-ylidene]-2-butenoic acid

Racemic (2Z,4E)-4-[3′,4′-dihydro-1′(2′H)-naphthalene-1′-ylidene]-2-butenoic acid (1) is a polyene chain-shortened analog of (9Z)-retinoic acid (3) which uses a tetrahydronaphthyl ring to conformationally constrain the C6-C7 single bond (retinoic acid numbering). The structure of (1) was obtained to determine the effects of the tetrahydronaphthyl ring on the ring to polyene chain conformation as compared to a published crystal structure for (9Z)-retinal (2). The results reveal significant differences between the solid state structures of (1) and (2), particularly for torsion angles about C6, C7 and C8, C9. The title compound crystallizes in the centrosymmetric monoclinic space groupP2₁/n withZ=4. (Cell dimensions:a=10.863(2) Å,b=7.637(2) Å,c=15.781(3) and β=106.11(3)°.) The structure was refined toR=3.88% for those 1132 unique data with |F _o|>6σ(F _o). In the crystal structure, the molecules adopt a hydrogen bonded dimeric structure.     

Synthesis and structure analysis of 2-(2′-propanonylthio)-3-(o-methyl phenyl) quinazol-4(3H)-one

The three-dimensional molecular and crystal structure of 2-(2'-propanonylthio)3-(o-methyl phenyl)quinazol-4(3H)-one has been determined by X-ray crystallographic methods. This compound crystallizes in the orthorhombic space group P_bca with unit cell parameters: a=9.649(5), b=30.102(10), c=11.403(9)Å. It has been solved by direct methods and refined to a residual index of 0.054. The magnitude of torsion along C16— C11— N3— C4 bond is 93.5(4)°. The dihedral angle between the plane comprising all the ring atoms of quinazoline moiety and the atoms of the methyl substituted phenyl ring is 94.12(1)°. The crystal structure is stabilized by one intramolecular C— HsO interaction and three intermolecular C— HsN contacts.     

Synthesis of (2,4-Diamino-5-(3′,4′,5′-trimethoxybenzyl) Pyrimidine) Copper (II) Complex at 20–25 °C and its Structural Characterization

Abstract  The title copper (II) complex with Trimethoprim was prepared at 20–25 °C and its crystal structure was determined by single crystal X-ray diffraction. Compound (C₃₆H₅₀Cu₃N₈O₁₆) is triclinic, space group P-1 with a = 6.4642(5) ?, b = 12.5495(9) ?, c = 13.4911(10) ?, α = 77.518(1)°, β = 85.326(1)°, γ = 84.413(2)°, Z = 1. In this compound, three copper atoms are bonded to each other, two terminal coppers are bonded to three oxygen atoms and N₁ of pyrimidine ring of Trimethoprim and central copper is bonded to four oxygen atoms. The amino nitrogen atoms are not involved in the coordination to the metal. Graphical Abstract  To enhance the activity of trimethoprim, its derivative was prepared and there bacterial activity against several bacteria was analyzed.      

Structural studies of N-2-(3-picolyl)- and N-2-(4-picolyl)-N′-tolylthioureas

Reactions of 2-aminopicolines with 2- and 4-tolyl isothiocyanates yielded N-2-(4-picolyl)-N-4-tolylthiourea, 1, N-2-(3-picolyl)-N-4-tolylthiourea, 2, and N-2-(4-picolyl)-N-2-tolylthiourea, 3. Compound 1 is monoclinic, of space group P2₁/c with a = 7.456(1) Å, b = 13.135(3) Å, c = 13.959(3) Å, = 104.99(3)°, and V = 1320.5(5) ų with Z = 4, for d _calc = 1.294 g/cm³. Compound 2 is triclinic, of space group with a = 6.877(3) Å, b = 7.590(5) Å, c = 13.213(9) Å, = 78.38(2)°, = 77.96(4)°, = 86.36(4)°, and V = 660.5(7) ų with Z = 2, for d _calc = 1.294 g/cm³. Compound 3 is monoclinic, of space group P2₁/c with a = 12.604(2) Å, b = 15.592(3) Å, c = 6.875(2) Å, = 91.05(2)°, and V = 1350.9(2) ų with Z = 4, for d _calc = 1.265 g/cm³. The three thioureas are found in both solid state and solution in a conformation resulting from intramolecular hydrogen bonding. Compounds 1 and 3 present an intermolecular hydrogen bond involving the thione sulfur and the NH hydrogen, which is not present in 2 owing to the steric hindrance of the methyl group in the phenyl ring. The geometry of the molecule is affected by the position of the methyl groups on the pyridine and aryl rings.     

Reinvestigation of the reaction of [Ru3(CO)12] with 2-mercaptobenzothiazole: X-ray structure of [(μ-H)2Ru3 (μ-η2-C7H4NS2)(μ3-η2-C7H4NS2)(CO)7]

Treatment of Ru₃(CO)₁₂ with 2-mercaptobenzothiazole at 68°C gave the known compound [(-H)Ru₃(₃-²-C₇H₄NS₂)(CO)₉] 1 and the new compound [(-H)₂Ru₃(-²-C ₇H₄NS₂) (₃-²-C₇H₄NS₂)(CO)₇] 2 in 15 and 10% yields respectively. Compound 2 has been characterized by elemental analysis, infrared, ¹H NMR and mass spectroscopic data together with single crystal X-ray crystallography. It crystallizes in the monoclinic space group C2/c with a = 31.662(6), b = 14.577(3), c = 11.602(2) Å, = 104.15(3)°, Z = 8, and V = 5192.4(2) ų. The compound consists of a Ru₃ triangle with three different Ru-Ru bond lengths [2.75264, 2.79084, 2.97604 Å] and the two 2-mercaptobenzothiazole ligands are differently attached to the metal atoms. Compound 2 is also obtained by the reaction of 1 with excess 2-mercaptobenzothiazole at 68°C.     

Crystal structure of 2,2,3-trimethyl-3-(2′,4′,5′-tricyanophenyl) cyclopentyl-1-acetic acid, methyl ester, C20H21N3O2

The title compound crystallizes in space group P2₁/n, with a = 14.600(2), b = 7.091(2), c = 18.211(5) Å, and = 103.67(2)°. Owing to the centric space group, both C(1) and C(3) chiral centers are either R or S. The acetate group is equatorial, the H(1) and the methyl group at C(3) are axial and reciprocally trans.     

Crystal Structure?4-(2,4-Dihydroxybenzylideneamino)-5-methyl-2H-1,2,4-triazol-3(4H)-one

Abstract  

The title compound (I), 4-(2,4-dihydroxybenzlideneamino)-5-methyl-2H-1,2,4-triazol-3(4H)-one was characterized by single crystal X-ray diffraction. This crystal is monoclinic, space group P2₁/c with a = 10.1447(7) ?, b = 7.0972(3) ?, c = 14.6726(10) ?, β = 98107(5)°, V = 1045.85(11) ?³, Z = 4, D _c = 1.487 g/cm³, F ₀₀ = 488, R = 0.039 and wR = 0.1025, S = 1.003, T = 293 (2) K. The title molecule is planar: the angle between the triazole ring and benzene ring is 179.1(1)°. The crystal structure contains two intramolecular (O–H···N and C–H···O) and three intermolecular interaction (O–H···N, N–H···O, and C–H···O). In addition, there is also π–π interactions.     

Crystal Structure of 3′-(4-Methoxyphenyl)-2-Phenyl-4′-(4-Ethoxyphenyl)-1,2-Dihydro-4H,4′H-Spiro [Isoquinoline-3,5′-Isoxazol]-4-One

The title compound, 3′-(4-methoxyphenyl)-2-phenyl-4′-(4-ethoxyphenyl)-1,2-dihydro-4H,4′H-spiro[isoquinoline-3,5′-isoxazol]-4-one was synthesized from the reaction of dipolarophile with p-methoxybenzadoxime in the presence of sodium hypochlorite in chloroform solution. The structure of the synthesized compound was determined by IR, ¹H NMR, mass spectroscopic data, ¹³C NMR spectroscopy, elemental analysis and X-ray crystallography. The structure was solved in monoclinic, space group C2/c with a = 21.941 (4), b = 17.233 (3), c = 15.404 (3) Å, β = 122.193 (2), V = 4928.9 (16) Å³, Z = 8 and with R_int = 0.154. The geometry of the title compound showed that the piperidine ring adopts a half-chair conformation. In the crystal structure, molecules are linked by C–H···O and C–H···N contacts. Weak C–H···π interactions plays an important role in stabilizing the supramolecular structure.